Inform, Empower, Connect

Donor Site Morbidity After Free Vascularized Fibular Graft

Last Update Posted : 2024-03-22

The aim of the trial

  • This study was carried out at Assiut University to Asses the long-term donor site morbidity following free vascularized fibular transfer because there is a limited information regarding the long-term donor morbidity of this type of flap.
Country
Egypt,
Locations
Assiut,
Trial Type
Observational
Trial Phase
-
Trial Status
Recruiting
Minimum age
18 Years
Maximum age
-
Key Contact
-Hedra Rafat Ishak, 00201069557727, hedra.rafat@yahoo.com,
Clinical Trial ID
NCT06324916

Key Information

  • -

How the treatment works

  • X rays for ankle to see distal fibular remenant
  • Visit our drugs and interventions page to find out more about this treatment, including how it works and what it’s used for.

Who is the trial for?

  • Patients done FVFG for reconstruction of bone defect other than lower limb bone defect.
  • surgery done >2yrs
  • Patient age > 18 yrs old

Who is the trial not for?

  • Patient age < 18 Surgery done< 2yrs FVFG for reconstruction of lower limb bone defct Amputated other leg : Above Ankle Amputaion Double FVFG Fracture of the other leg side : Fracture Tibia, Fibula, Ankle Paraplegic patients

Disclaimer

  • ONTEX is intended to supplement, not replace, your healthcare team. Patients should always discuss a clinical trial with their healthcare team. If a patient is eligible for a trial the trial team will be able to provide more in-depth information about the trial so the patient can make an informed decision before taking part. Trial information has been sourced from www.clinicaltrials.gov. The content is then reviewed weekly by the Osteosarcoma Now team. All the trials also have a patient-friendly summary and key information section written by the team at Osteosarcoma Now. We have also included a description of the medications being used in the trial and summarised the inclusion and exclusion criteria in the ‘who is this trial (not) for’ sections. To the best of our knowledge the clinical trial database is up-to-date and accurate.However, we cannot assume any liability for the accuracy or completeness of the information.